Schedule 13G ownership disclosure
CRINETICS PHARMACEUTICALS INC
Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 22663K107
Event date: 2025-08-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Farallon Capital Partners, L.P.
Shares: 397,728 · Class: 0.4%
- Farallon Capital Institutional Partners, L.P.
Shares: 512,807 · Class: 0.5%
- Farallon Capital Institutional Partners II, L.P.
Shares: 123,290 · Class: 0.1%
- Farallon Capital Institutional Partners III, L.P.
Shares: 67,865 · Class: 0.1%
- Four Crossings Institutional Partners V, L.P.
Shares: 92,559 · Class: 0.1%
- Farallon Capital Offshore Investors II, L.P.
Shares: 928,042 · Class: 1%
- Farallon Capital (AM) Investors, L.P.
Shares: 55,239 · Class: 0.1%
- Farallon Capital F5 Master I, L.P.
Shares: 142,177 · Class: 0.2%
- Farallon Healthcare Partners Master, L.P.
Shares: 3,305,391 · Class: 3.5%
- Farallon Partners, L.L.C.
Shares: 5,482,921 · Class: 5.8%
- Farallon Institutional (GP) V, L.L.C.
Shares: 92,559 · Class: 0.1%
- Farallon F5 (GP), L.L.C.
Shares: 142,177 · Class: 0.2%
- Farallon Healthcare Partners (GP), L.L.C.
Shares: 3,305,391 · Class: 3.5%
- Dapice Joshua J.
Shares: 5,625,098 · Class: 6%
- Dreyfuss, Philip D.
Shares: 5,625,098 · Class: 6%
- Dunn Hannah E.
Shares: 5,625,098 · Class: 6%
- Fried, Richard B
Shares: 5,625,098 · Class: 6%
- Gehani, Varun N.
Shares: 5,625,098 · Class: 6%
- Giauque, Nicolas
Shares: 5,625,098 · Class: 6%
- Kim, David T.
Shares: 5,625,098 · Class: 6%
- Linn, Michael G.
Shares: 5,625,098 · Class: 6%
- Luo Patrick (Cheng)
Shares: 5,625,098 · Class: 6%
- Patel, Rajiv A.
Shares: 5,625,098 · Class: 6%
- Roberts, Jr., Thomas G.
Shares: 5,625,098 · Class: 6%
- Saito Edric C.
Shares: 5,625,098 · Class: 6%
- Seybold, William
Shares: 5,625,098 · Class: 6%
- Short Daniel S.
Shares: 5,625,098 · Class: 6%
- Spokes, Andrew J. M.
Shares: 5,625,098 · Class: 6%
- Warren, John R.
Shares: 5,625,098 · Class: 6%
- Wehrly, Mark C.
Shares: 5,625,098 · Class: 6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-25-000292
- Form type
- SCHEDULE 13G
- Filer
- Crinetics Pharmaceuticals, Inc.
- CIK
- CIK 1658247
- Filed
- Sep 08, 2025
- Reporting period
- Aug 29, 2025
- Description
- Schedule 13G beneficial ownership